Page 703 - Equine Clinical Medicine, Surgery and Reproduction, 2nd Edition
P. 703

678                                        CHAPTER 3



  VetBooks.ir  Immunostimulants (e.g. inactivated Propionibacterium   to susceptible horses. The disease is OIE listed and is
                                                          notifiable in many countries. EVA can be controlled
           acnes, mycobacterial cell wall abstracts or interferon
           alpha) are used by some practitioners in horses with
           suspected chronic post-viral disease, but such prod-  by vaccination.
           ucts are not licensed in all countries and are not  Aetiology/pathophysiology
           indicated  for  acute  disease.  In  cases  that  develop   EVA is caused by a togavirus and has worldwide dis-
           neurological disease supportive care should be pro-  tribution. The virus is mainly transmitted directly
           vided. Nucleoside analogues antiviral drugs can be   from horse to horse by aerosolised respiratory secre-
           used in those cases, such as p/o or i/v acyclovir and   tions and venereally from carrier stallions to mares.
           p/o valacyclovir, but these compounds have poor   Indirect transmission via fomites is also possible.
           bioavailability in horses and reports with convincing   There is initial virus replication in the respiratory
           clinical benefits in horses are currently lacking.  tract followed by cell-associated viraemia, which dis-
             Vaccination against EHV-1 and EHV-4 assists in   seminates virus to the reproductive tract. Viraemia
           disease control by decreasing nasal virus shedding,   is associated with a leucopenia, principally a lym-
           thus reducing the spread of the virus, and reduc-  phopenia, and a leucocytosis, mainly a  lymphocy-
           ing the frequency of abortion. Current vaccines are   tosis, develops on recovery. Virus replication in the
           licensed for control of respiratory disease and abor-  walls of small arteries and veins causes vasculitis.
           tion. No vaccines possess a marketing authorisation   In stallions, persistent infection of  the accessory
           for control of neurological disease. However, the   sex glands, mainly the ampulla, is established and
           licensed vaccine in Europe and the licensed vaccines   infectious virus is shed in semen for several years,
           in  the rest of the world have all demonstrated the   although semen quality and fertility are not affected.
             ability to reduce virus replication in vaccinated horses   Infection of mares via venereal or respiratory routes
           and so may be helpful in preventing neurological dis-  at the time of covering causes early embryonic
           ease. Practitioners should be aware that the use of   death. Infection of pregnant mares at any time of
             vaccines to aid control of neurological disease consti-  gestation via the respiratory route causes fetal death.
           tutes off-label use, which in Europe requires informed   Serological surveys in the UK have revealed marked
           consent from the owner or keeper of the animal.  breed differences in the incidence of seropositive
                                                          horses  and  carrier  stallions,  presumably reflecting
           Prognosis                                      differences in stud management and practice, with
           The prognosis is good for respiratory disease,   Standardbreds having a significantly higher inci-
           although some horses may develop chronic fatigue/  dence than other breeds.
           poor  performance  syndromes.  Mares  that  have
           aborted usually successfully breed in the next season.  Clinical presentation
           The prognosis for neurological cases varies signifi-  The incubation period has an average of 7 days but
           cantly, with more severely affected horses (recum-  seems to be highly variable in the field, possibly up to
           bent) sometimes requiring euthanasia on welfare   21 days. Initial clinical signs are pyrexia, depression
           grounds and less severely affected horses making a   and anorexia. Clinically obvious respiratory disease
           full recovery.                                 may develop, but in many mares and stallions disease
                                                          is mild or subclinical. Respiratory signs, if present,
           EQUINE VIRAL ARTERITIS                         are  typical  of  infectious  URT disease  and  include
                                                          nasal  discharge,  lymphadenopathy  and  coughing.
           Definition/overview                            There may be marked conjunctivitis and lacrima-
           EVA causes respiratory disease and abortion and   tion. In some horses there are clinical signs relating
           thus shares many clinical features in common with   to vasculitis including conjunctival and periorbital
           EHV-1 infection. Stallions become carriers, shed-  oedema, scrotal and preputial oedema and oedema
           ding infectious virus in semen, and they are the   of the limbs. There are usually no clinical signs
           main reservoir of infection and transmission of virus   relating to early embryonic death. Where abortion
   698   699   700   701   702   703   704   705   706   707   708